Compare · CHNA vs DWSH

CHNA vs DWSH

Side-by-side comparison of Loncar China BioPharma ETF (CHNA) and AdvisorShares Dorsey Wright Short ETF (DWSH): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both CHNA and DWSH operate in n/a (n/a), so they compete in similar markets.
MetricCHNADWSH
Company
Loncar China BioPharma ETF
AdvisorShares Dorsey Wright Short ETF
Price
-
-
Market cap
-
-
1M return
-
-
1Y return
-
-
Sector
n/a
n/a
Industry
n/a
n/a
Exchange
NASDAQ
NASDAQ
IPO
n/a
n/a
News (4w)
0
0
Recent ratings
0
0
CHNA

Loncar China BioPharma ETF

The investment seeks to track the performance, before fees and expenses, of the Loncar China BioPharma Index (the index). Under normal circumstances, at least 80% of the fund's total assets (exclusive of any collateral held from securities lending) will be invested in the component securities of the index or in depositary receipts representing such component securities. The index seeks to track the performance of a modified equal-weighted portfolio of companies directly involved in the growth of China's pharmaceutical and biotech related industries. The fund is non-diversified.

DWSH

AdvisorShares Dorsey Wright Short ETF

The investment seeks capital appreciation through short selling securities. Dorsey, Wright & Associates, LLC (the "Sub-Advisor"), the sub-advisor to the fund, seeks to achieve the fund's investment objective by obtaining short exposure to investment returns of the broad U.S. large-capitalization equity market by engaging in short sales of U.S.-traded equity securities and exchange-traded funds ("ETFs"). Under normal circumstances, it invests at least 80% of its net assets (plus any borrowings for investment purposes) in investments that create or result in short exposure to U.S. equity securities.